Brain Tumor

You have access
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
Ruichao Chai, Guanzhang Li, Yuqing Liu, Kenan Zhang, Zheng Zhao, Fan Wu, Yuzhou Chang, Bo Pang, Jingjun Li, Yangfang Li, Tao Jiang and Yongzhi Wang

Cancer Biology & Medicine February 2021, 18 (1) 271-282; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0179
You have access
BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas
Shangfeng Gao, Zhuang Sha, Junbo Zhou, Yihao Wu, Yunnong Song, Cheng Li, Xuejiao Liu, Tong Zhang and Rutong Yu

Cancer Biology & Medicine February 2021, 18 (1) 88-104; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0096
You have access
HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and in vivo antitumor efficacy of paclitaxel in an orthotopic brain tumor model
Wu Zeng, Betty Yuen Kwan Law, Vincent Kam Wai Wong, Denise So Bik Chan, Simon Wing Fai Mok, Joyce Jia Ying Gao, Rebecca Ka Yan Ho, Xu Liang, Jia Hao Li, Ming Tsung Lee, Weng Li Yoon, Michael P Smolinski, Johnson Yiu Nam Lau, Christopher Wai Kei Lam and Manson Fok

Cancer Biology & Medicine November 2020, 17 (4) 986-1001; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0128
You have access
Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
Shaoping Shen, Ling Chen, Jialin Liu, Lin Yang, Mengna Zhang, Lingxiong Wang, Rong Zhang, Yasushi Uemura, Qiyan Wu, Xinguang Yu and Tianyi Liu

Cancer Biology & Medicine August 2020, 17 (3) 555-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0027
You have access
Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway
Yulong Lan, Jiacheng Lou, Jiliang Hu, Zhikuan Yu, Wen Lyu and Bo Zhang

Cancer Biology & Medicine February 2020, 17 (1) 112-131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0164
You have access
Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis
Caijun Zha, Xiangqi Meng, Lulu Li, Shan Mi, Da Qian, Ziwei Li, Pengfei Wu, Shaoshan Hu, Shihong Zhao, Jinquan Cai and Yanhong Liu

Cancer Biology & Medicine February 2020, 17 (1) 154-168; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0353
You have access
Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis
Yingbin Xie, Yanli Tan, Chao Yang, Xuehao Zhang, Can Xu, Xiaoxia Qiao, Jianglong Xu, Shaohui Tian, Chuan Fang and Chunsheng Kang

Cancer Biology & Medicine November 2019, 16 (4) 784-796; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0143
You have access
A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses
Mianfu Cao, Juan Cai, Ye Yuan, Yu Shi, Hong Wu, Qing Liu, Yueliang Yao, Lu Chen, Weiqi Dang, Xiang Zhang, Jingfang Xiao, Kaidi Yang, Zhicheng He, Xiaohong Yao, Yonghong Cui, Xia Zhang and Xiuwu Bian

Cancer Biology & Medicine August 2019, 16 (3) 595-605; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0277
You have access
TNFa inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNFa signaling
Li Ma, Chunhua She, Qian Shi, Qiang Yin, Xinxin Ji, Yongrong Wang, Yulong Fan, Xinyao Kong, Peng Li, Zengfeng Sun, Xiaohui Zhang, Zhen Zhang, Jian Wang, Tong Wang, Yuanfu Xu and Wenliang Li

Cancer Biology & Medicine August 2019, 16 (3) 606-617; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0011
You have access
Circular RNAs and human glioma
Jinglei Liu, Kun Zhao, Nunu Huang and Nu Zhang

Cancer Biology & Medicine February 2019, 16 (1) 11-23; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0425

Main menu

User menu

Search

Brain Tumor

Navigate

More Information

For Authors

Journal Services